[go: up one dir, main page]

ID23250A - Komposisi paroksetin - Google Patents

Komposisi paroksetin

Info

Publication number
ID23250A
ID23250A IDW990687A ID990687A ID23250A ID 23250 A ID23250 A ID 23250A ID W990687 A IDW990687 A ID W990687A ID 990687 A ID990687 A ID 990687A ID 23250 A ID23250 A ID 23250A
Authority
ID
Indonesia
Prior art keywords
paroxsetin
composition
paroxsetin composition
Prior art date
Application number
IDW990687A
Other languages
English (en)
Inventor
Jacewicz Victor Witold
Ward Neal
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9700692.8A external-priority patent/GB9700692D0/en
Priority claimed from GBGB9714873.8A external-priority patent/GB9714873D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ID23250A publication Critical patent/ID23250A/id

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1688Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IDW990687A 1997-01-15 1998-01-12 Komposisi paroksetin ID23250A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9700692.8A GB9700692D0 (en) 1997-01-15 1997-01-15 Novel process and compound
GBGB9714873.8A GB9714873D0 (en) 1997-07-15 1997-07-15 Novel process and compound

Publications (1)

Publication Number Publication Date
ID23250A true ID23250A (id) 2000-03-30

Family

ID=26310796

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW990687A ID23250A (id) 1997-01-15 1998-01-12 Komposisi paroksetin

Country Status (21)

Country Link
US (1) US20010049442A1 (id)
EP (1) EP0952831A1 (id)
JP (1) JP2001508460A (id)
KR (1) KR20000070151A (id)
CN (1) CN1249686A (id)
AP (1) AP9901604A0 (id)
AU (1) AU730532B2 (id)
BG (1) BG103648A (id)
BR (1) BR9806754A (id)
CA (1) CA2277480A1 (id)
EA (1) EA002034B1 (id)
HU (1) HUP0000960A3 (id)
ID (1) ID23250A (id)
IL (1) IL130856A (id)
NO (1) NO993460L (id)
NZ (1) NZ336587A (id)
OA (1) OA11077A (id)
PL (1) PL334568A1 (id)
SK (1) SK95099A3 (id)
TR (1) TR199901622T2 (id)
WO (1) WO1998031365A1 (id)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9724544D0 (en) * 1997-11-21 1998-01-21 Smithkline Beecham Plc Novel Formulation
US6168805B1 (en) * 1998-05-07 2001-01-02 Endo Pharmaceuticals, Inc. Aqueous process for manufacturing paroxetine solid dispersions
GB9810181D0 (en) * 1998-05-13 1998-07-08 Smithkline Beecham Plc Novel formulations
AU5428999A (en) * 1998-08-07 2000-02-28 Smithkline Beecham Plc Process for the preparation of a non-crystalline anhydrate form of paroxetine hydrochloride
GB9824298D0 (en) * 1998-11-05 1998-12-30 Smithkline Beecham Plc Novel process
EP1161241B1 (de) 1999-03-12 2005-12-07 Aesica Pharmaceuticals Ltd. Stabile pharmazeutische anwendungsform für paroxetin-anhydrat
GB9914600D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel,process
ES2162560B1 (es) * 1999-06-25 2002-07-16 Rodriguez Concepcion Pena Uso de fluoxetina, paroxetina y otros isrs para la fabricacion de medicamentos con el fin de aumentar la capacidad de abstenerse de substancias o actividades que crean dependencia.
ATE248165T1 (de) 1999-07-01 2003-09-15 Italfarmaco Spa Komplexe von paroxetin mit cyclodextrin oder cyclodextrin derivaten
GB9919052D0 (en) * 1999-08-12 1999-10-13 Smithkline Beecham Plc Novel compound composition and process
GB9923446D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
GB9923439D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
US6660298B1 (en) * 2000-07-27 2003-12-09 Pentech Pharmaceuticals, Inc. Paroxetine tablets and capsules
NZ523902A (en) * 2000-08-28 2004-05-28 Synthon Bv Paroxetine compositions and processes for making the same
WO2006023347A1 (en) * 2004-08-20 2006-03-02 Alpharma, Inc. Paroxetine formulations
CN104027306A (zh) * 2014-06-25 2014-09-10 万特制药(海南)有限公司 帕罗西汀口服混悬液及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2297550B (en) * 1995-02-06 1997-04-09 Smithkline Beecham Plc Paroxetine hydrochloride anhydrate substantially free of bound organic solvent
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride

Also Published As

Publication number Publication date
HUP0000960A2 (hu) 2001-02-28
BG103648A (en) 2000-04-28
KR20000070151A (ko) 2000-11-25
EP0952831A1 (en) 1999-11-03
AU730532B2 (en) 2001-03-08
JP2001508460A (ja) 2001-06-26
OA11077A (en) 2003-03-13
AP9901604A0 (en) 1999-09-30
BR9806754A (pt) 2000-03-14
CA2277480A1 (en) 1998-07-23
WO1998031365A1 (en) 1998-07-23
EA199900655A1 (ru) 2000-02-28
IL130856A (en) 2001-09-13
PL334568A1 (en) 2000-03-13
EA002034B1 (ru) 2001-12-24
US20010049442A1 (en) 2001-12-06
NZ336587A (en) 2001-01-26
NO993460D0 (no) 1999-07-14
TR199901622T2 (xx) 1999-09-21
HUP0000960A3 (en) 2001-04-28
IL130856A0 (en) 2001-01-28
NO993460L (no) 1999-09-14
CN1249686A (zh) 2000-04-05
SK95099A3 (en) 2000-01-18
AU5567398A (en) 1998-08-07

Similar Documents

Publication Publication Date Title
IS5430A (is) Ný samsetning
ID22931A (id) Komposisi-komposisi herbisidal
DK1298194T3 (da) Staniolholdige sammensætninger
DE69718508D1 (de) Antitraspirant zusammensetzung
ID26186A (id) Komposisi sampo
ID28694A (id) Komposisi sampo
ATE250583T1 (de) Substituierte 3-cyanochinoline
DE69832516D1 (de) Isoflavon-enthaltende zusammensetzungen
ID29430A (id) Komposisi herbisida
ID25508A (id) Komposisi dematologis
ID18359A (id) Komposisi mikrokapsul
DE69942892D1 (de) Gaserzeugende zusammensetzung
DE69928862D1 (de) Zusammensetzung
ID21009A (id) Komposisi untuk supositori
ID23250A (id) Komposisi paroksetin
ID25650A (id) Komposisi-komposisi sampo
ID21906A (id) Komposisi adesif
DE59813487D1 (de) Substituierte 4-benzoyl-pyrazole
ID19589A (id) Komposisi
DE69826706D1 (de) Wäscheweichmittelzusammensetzungen
NO20002555D0 (no) Skjøt
BR9707835A (pt) Composiç
BR9709815A (pt) Composicão
ID26295A (id) Komposisi keras-ultraviolet
FI19992526A (fi) Sahakokoonpano